Furthermore, EZH2 has been shown to associate with the internal ribosome entry site (IRES) of p53 mRNA, selectively enhancing the translation of gain-of-function (GOF) p53 variants, thereby facilitating tumor progression and metastatic potential 9. This evidence concerns the gene TP53 and neoplasm.